Cite Filings / CTOR / 0001213900-25-122793
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13D/A

Beneficial Ownership Report

CITIUS ONCOLOGY, INC. · Filed 2025-12-17 · Acc 0001213900-25-122793

Documents 1

  • SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

  • 2026-06-04 SCHEDULE 13D/A Beneficial Ownership Report
  • 2025-12-22 4/A Secretary acquired 850,000 shares (grant or award)
  • 2025-12-22 4/A Chief Financial Officer acquired 825,000 shares (grant or award)
  • 2025-12-22 4/A Chief Medical Officer acquired 825,000 shares (grant or award)
  • 2025-12-22 4/A Chief Executive Officer acquired 1,700,000 shares (grant or award)
  • 2025-12-17 SCHEDULE 13D/A Beneficial Ownership Report
  • 2025-09-12 SCHEDULE 13D/A Beneficial Ownership Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…